Quviviq is not currently approved for sale in Canada, and therefore, there is no established price for the drug in the Canadian market [1].
When might Quviviq be available in Canada?
The availability of Quviviq in Canada depends on Health Canada's review and approval process. As of now, there is no publicly announced timeline for its potential approval and launch in Canada [1].
What is Quviviq and what is it used for?
Quviviq (daridorexant) is a medication approved in the United States for the treatment of insomnia in adults. It works by blocking the activity of orexins, which are substances in the brain that promote wakefulness [2].
How does Quviviq compare to other insomnia treatments?
Quviviq is a dual orexin receptor antagonist, a class of medication distinct from other insomnia treatments like benzodiazepines or non-benzodiazepine hypnotics. Its mechanism of action focuses on reducing the brain's drive for wakefulness [2].
Are there any patents for Quviviq in Canada?
Information regarding specific patent filings and expiry dates for Quviviq in Canada would typically be available through specialized patent tracking databases [3]. DrugPatentWatch.com provides such information for various pharmaceuticals.
Who is the manufacturer of Quviviq?
Quviviq is developed and manufactured by Idorsia Pharmaceuticals [1].
What is the price of Quviviq in the United States?
In the United States, the retail price for Quviviq can vary. For example, a 30-day supply of 25 mg tablets may be around $430 USD, and a 30-day supply of 50 mg tablets may be around $480 USD. However, actual costs can be lower with insurance or patient assistance programs [4].
What are the potential side effects of Quviviq?
Common side effects of Quviviq include sleep paralysis, auditory or visual hallucinations, and temporary muscle weakness (cataplexy). It also carries a risk of suicidal thoughts and behaviors. Patients are advised to avoid driving or operating machinery after taking Quviviq until they know how it affects them [2].
What clinical data supports Quviviq's efficacy?
Quviviq's approval in the U.S. was based on clinical trials demonstrating its effectiveness in improving sleep onset and sleep maintenance in adults with insomnia [2].
What are the regulatory hurdles for Quviviq in Canada?
For Quviviq to be available in Canada, it must undergo a rigorous review by Health Canada to assess its safety, efficacy, and quality. This process determines whether the drug meets Canadian standards for approval [1].
Sources:
1. https://www.drugpatentwatch.com/
2. Idorsia Pharmaceuticals. (n.d.). Quviviq™ (daridorexant) Prescribing Information.
3. DrugPatentWatch.com. (n.d.). Quviviq.
4. GoodRx. (n.d.). Quviviq Prices, Coupons, and Patient Assistance Programs.